JPH07506352A - フラビウイルス感染の治療におけるヘテロポリタングステン酸塩 - Google Patents

フラビウイルス感染の治療におけるヘテロポリタングステン酸塩

Info

Publication number
JPH07506352A
JPH07506352A JP5518767A JP51876793A JPH07506352A JP H07506352 A JPH07506352 A JP H07506352A JP 5518767 A JP5518767 A JP 5518767A JP 51876793 A JP51876793 A JP 51876793A JP H07506352 A JPH07506352 A JP H07506352A
Authority
JP
Japan
Prior art keywords
znii
tiiv
coii
ceremony
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5518767A
Other languages
English (en)
Japanese (ja)
Inventor
ウェイゴールド、ヘルマット
バーソロメウズ、アンジェリン・イングリッド
ホラン、ジョージ
マルクッキオ、セバスチャン・マリオ
ライト、ペーター・ジェームス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of JPH07506352A publication Critical patent/JPH07506352A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP5518767A 1992-05-01 1993-04-30 フラビウイルス感染の治療におけるヘテロポリタングステン酸塩 Pending JPH07506352A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPL221392 1992-05-01
AU2213 1992-05-01
PCT/AU1993/000192 WO1993021934A1 (en) 1992-05-01 1993-04-30 Heteropolytungstates in the treatment of flavivirus infections

Publications (1)

Publication Number Publication Date
JPH07506352A true JPH07506352A (ja) 1995-07-13

Family

ID=3776137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5518767A Pending JPH07506352A (ja) 1992-05-01 1993-04-30 フラビウイルス感染の治療におけるヘテロポリタングステン酸塩

Country Status (6)

Country Link
JP (1) JPH07506352A (es)
CN (1) CN1082892A (es)
CA (1) CA2134877A1 (es)
HU (1) HUT71677A (es)
MX (1) MX9302578A (es)
WO (1) WO1993021934A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824706A (en) * 1994-09-26 1998-10-20 Schinazi; Raymond F. Method, compositions, and apparatus for treating and preventing respiratory viral infections
AUPO820197A0 (en) * 1997-07-24 1997-08-14 Biomolecular Research Institute Limited Inorganic angiogenesis inhibitors
AUPO995297A0 (en) * 1997-10-24 1997-11-13 Starpharma Limited Inorganic antiviral compounds
IL141456A0 (en) * 1998-08-21 2002-03-10 Viropharma Inc Rhodanine derivatives and pharmaceutical compositions containing the same
DE102006023394A1 (de) * 2006-05-17 2007-11-22 Gerd Prof. Wengler Herstellung und Verwendung eines antiviralen Chemotherapeutikums welches eine Wirtszelle dahingehend beeinflusst, dass die Replikation von Viren in der Zelle blockiert wird
CN107226462A (zh) * 2016-03-24 2017-10-03 李泽琳 多酸化合物、其制备方法和医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2117803B1 (es) * 1970-12-18 1974-03-22 Anvar
WO1990006756A1 (en) * 1988-12-16 1990-06-28 Terumo Kabushiki Kaisha Antiviral agent
GB8906189D0 (en) * 1989-03-17 1989-05-04 Johnson Matthey Plc Improvements in chemical compounds
GB9003430D0 (en) * 1990-02-15 1990-04-11 Johnson Matthey Plc Improvements in chemical compounds
GB9025847D0 (en) * 1990-11-28 1991-01-09 Johnson Matthey Plc Improvements in chemical compounds

Also Published As

Publication number Publication date
MX9302578A (es) 1994-08-31
HUT71677A (en) 1996-01-29
WO1993021934A1 (en) 1993-11-11
CN1082892A (zh) 1994-03-02
CA2134877A1 (en) 1993-11-11
HU9403128D0 (en) 1995-02-28

Similar Documents

Publication Publication Date Title
JP6892494B2 (ja) パラセタモール及びイブプロフェンを含む水性配合物
MIYAZAKI et al. Antitumor effect of pluronic F-127 gel containing mitomycin C on sarcoma-180 ascites tumor in mice
EP3150212B1 (en) Pharmaceutical solution having anti-tumor effect-enhancing and toxicity-reducing effect, and pharmaceutical composition comprising same
WO2017096530A1 (zh) 癸氧喹酯固体分散体、其制备方法和用途
WO2007033578A1 (fr) Metallo-fullerenols et leur application dans la preparation de medicaments visant a inhiber la croissance tumorale
CN105903021A (zh) 一种预防和/或治疗再生障碍性贫血的富勒烯纳米材料及其应用
WO1995011033A1 (en) Polyoxometallates in the treatment of flavivirus infections
KR20160008523A (ko) 종양 독성과 mri를 위한 표적화 콜롤
WO2004030649A3 (de) Methode zur herstellung und stabilisierung von mikro- und nanosuspensionen mit amphiphilen und polyelektrolyten
JPH07506352A (ja) フラビウイルス感染の治療におけるヘテロポリタングステン酸塩
Stoll et al. In vitro dissolution and in vivo absorption of nitrofurantoin from deoxycholic acid coprecipitates
CN112040954A (zh) 用于预防或治疗黄病毒感染症的药物组合物
CN1968686B (zh) 脒腙盐、组合物、制备方法和使用方法
JPS6328045B2 (es)
CN107137349B (zh) 一种藤黄酸纳米混悬剂及其制备方法
KR20170072355A (ko) C형 간염에 대한 장기 작용 약학적 조성물
EP4140480A1 (en) Drug combination and use thereof
TW584563B (en) Parenteral formulation
CN108392483B (zh) 一种紫杉醇联合2-甲氧基雌二醇的白蛋白纳米粒的制备方法及应用
WO1994012192A1 (en) Antiviral agents
JP2007326796A (ja) 金コロイドを含有する美白剤およびチロシナーゼ阻害剤
Miao et al. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo
Choi et al. The Next Generation COVID‐19 Antiviral; Niclosamide‐Based Inorganic Nanohybrid System Kills SARS‐CoV‐2
AU4255593A (en) Heteropolytungstates in the treatment of flavivirus infections
CN116327699A (zh) 一种增强橙皮素治疗急性肝损伤效果的纳米胶束的制备及应用